通过使用药理平衡建模的GluN2A选择性对抗剂对全性NMDA受体调节的评估
James S Lotti1, Jaron Jones2, Jill C Farnsworth2
1University of Montana, United States.
Molecular pharmacology
|November 5, 2024
概括
一个新的模型量化了NMDA受体调节器活性,揭示了GluN2A选择性负基调节器 (NAM) 之间的差异. 这有助于通过理解结构-活动关系来设计治疗大脑疾病的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- NMDA类型的离子型谷氨酸受体对大脑功能至关重要,它们的功能障碍与神经系统疾病有关.
- 向特定NMDA受体亚型的度调节器具有治疗潜力,但由于缺乏操作模型,它们的评估受到阻碍.
研究的目的:
- 开发和应用药理平衡模型来表征NMDA受体激活和全调节.
- 为了更深入地了解像TCN-201,MPX-004和MPX-007.7这样的GluN2A选择性负基调制剂 (NAM),
主要方法:
- 开发了一种新型的联体受体模型,以量化调节器结合亲和力 (KB) 以及对激动剂结合亲和力 (α) 和疗效 (β) 的影响.
- 该模型被应用于研究GluN2A选择性NAM,使用半平衡条件来评估它们与NMDA受体的相互作用.
主要成果:
- 该研究量化了TCN-201,MPX-004和MPX-007对GluN1/2A受体的结合和调节效应,揭示了不同的配置文件.
- 与MPX-004 (KB = 9.3 nM,β = 1.19) 和MPX-007 (KB = 1.1 nM,β = 0.82) 相比,TCN-201的结合能力较弱 (KB = 42 nM) 并且激素疗效降低 (β = 0.76),与MPX-004 (KB = 9.3 nM,β = 1.19) 相比.
- 这些调节效应在具有不同子单元组成 (二异构和三异构) 的受体中一致.
结论:
- 开发的药理学模型为评估NMDA受体全调节器提供了定量框架.
- 对NAM的表征突出了它们的结合和疗效调节的差异,为它们作为研究工具的使用提供了信息,并指导了新治疗剂的设计.
相关概念视频
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Allosteric Regulation
57.7K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.7K
Antiepileptic Drugs: Glutamate Antagonists
284
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
284


